Literature DB >> 1605640

Dexamethasone up-regulates mannose receptor activity by increasing mRNA levels.

H B Cowan1, S Vick, J T Conary, V L Shepherd.   

Abstract

The macrophage mannose receptor is highly susceptible to modulation by a variety of inflammatory and anti-inflammatory agents. Previous studies have demonstrated that mannose receptor activity is dramatically enhanced in rat bone marrow macrophages following treatment with dexamethasone. In the present study we have investigated potential mechanisms that might be involved in this up-regulation. Uptake of ligands by the mannose receptor was increased 2.5-fold in a dose- and time-dependent manner. Maximal stimulation was seen following treatment of macrophages with 0.1-1.0 microgram/ml of dexamethasone for 24-48 h. Dexamethasone treatment increased both the number of cell surface binding sites and total cellular binding activity to 250% of control levels. In addition, total receptor protein as measured by immunoprecipitation was increased 2.5-fold. Neither the maturation rate nor the turnover rate of the protein was altered by dexamethasone treatment. Using an oligonucleotide probe derived from sequence data from the cloned human receptor cDNA, we investigated the effect of dexamethasone on the expression of mannose receptor mRNA. Following incubation with dexamethasone for 12-24 h, the level of mRNA was significantly increased. These results demonstrate that dexamethasone treatment of rat bone marrow macrophages induces synthesis of new receptor protein through an increase in the level of mannose receptor mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1605640     DOI: 10.1016/0003-9861(92)90578-k

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Chronic administration of dexamethasone results in Fc receptor up-regulation and inhibition of class I antigen expression on macrophages from MRL/lpr autoimmune mice.

Authors:  S H Zuckerman; G F Evans; N Bryan
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Glucocorticoids modulate the development of dendritic cells from blood precursors.

Authors:  M M van den Heuvel; N M van Beek; E Broug-Holub; P E Postmus; E C Hoefsmit; R H Beelen; G Kraal
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.

Authors:  C Schebesch; V Kodelja; C Müller; N Hakij; S Bisson; C E Orfanos; S Goerdt
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

4.  CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells.

Authors:  Jason Caulfield; Maria Fernandez; Vladimir Snetkov; Tak Lee; Catherine Hawrylowicz
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

5.  Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis.

Authors:  N Djemadji-Oudjiel; S Goerdt; V Kodelja; M Schmuth; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

6.  Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor.

Authors:  Abdel Motaal M Ahmed; Abdel Gadir Y Kadaru; Ibtihal Omer; Ahmed M Musa; Khalid Enan; Isam M El Khidir; Roger Williams
Journal:  J Clin Exp Hepatol       Date:  2014-09-16

7.  Characterization of functional mannose receptor in a continuous hybridoma cell line.

Authors:  David J Vigerust; Sherell Vick; Virginia L Shepherd
Journal:  BMC Immunol       Date:  2012-09-12       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.